(Q37776807)

23 August 2017

1 reference

title

Methods for measuring proteasome activity: current limitations and future developments (English)

1 reference

23 August 2017

Methods for measuring proteasome activity: Current limitations and future developments (English)

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

14 June 2024

2

L. J. Crawford

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674016

14 June 2024

author name string

A. Liggett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674016

14 June 2024

B. Walker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674016

14 June 2024

T. C M. Morris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674016

14 June 2024

A. E. Irvine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674016

14 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20674016

14 June 2024

publication date

31 July 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0145212610003279?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

https://api.elsevier.com/content/article/PII:S0145212610003279?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

14 June 2024

1 reference

23 August 2017

volume

34

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

1403-1409

1 reference

Proteasome inhibitors: valuable new tools for cell biologists

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

14 June 2024

The ubiquitin system

2

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Proteasomes from structure to function: perspectives from Archaea

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

The structure of the mammalian 20S proteasome at 2.75 A resolution

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Role of the proteasome in Alzheimer’s disease

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Impaired proteasome function in Alzheimer's disease

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Large‐ and Small‐Scale Purification of Mammalian 26S Proteasomes

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

The proteasome: a novel therapeutic target in haematopoietic malignancy

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Characterization of noncompetitive regulators of proteasome activity

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Purification and proteomic analysis of 20S proteasomes from human cells.

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells.

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Assays of proteasome activity in relation to aging

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Assays for proteasome inhibition

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Profiling proteasome activity in tissue with fluorescent probes

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Affinity labeling of the proteasome by a belactosin A derived inhibitor

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Azido-BODIPY acid reveals quantitative Staudinger-Bertozzi ligation in two-step activity-based proteasome profiling

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Activity-based protein profiling: from enzyme chemistry to proteomic chemistry

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Cell surface engineering by a modified Staudinger reaction

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

A Comparative Study of Bioorthogonal Reactions with Azides

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Imaging 26S proteasome activity and inhibition in living mice

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: technical considerations for design and use of genetically encoded reporters

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Immunological methods to quantify and characterize proteasome complexes: development and application.

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Purification, crystallization, and X-ray analysis of the yeast 20S proteasome

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

Homogeneous, bioluminescent protease assays: caspase-3 as a model

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.07.003

14 June 2024

Identifiers

1 reference

23 August 2017

1 reference